The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society

Öz:

Background/Aims: To translate the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire from English to Turkish and to validate it.Materials and Methods: UCLA SCTC GIT 2.0 was translated into Turkish using the translation-retranslation method. The available Turkish GIT 2.0 and the Short Form 36 (SF-36) were administered to 97 Turkish-speaking patients with systemic sclerosis (Ssc). Internal consistency reliability and structural validity were assessed by analyzing the correlations between the UCLA SCTC GIT 2.0 and the SF-36 scales. Internal consistency was determined by calculating Cronbach’s alpha. For evaluation of reliability, the questionnaire scale was repeatedly applied to a subgroup of patients with a 2-week interval, and the intraclass correlation coefficient (ICC) was calculated. The Spearman’s correlation coefficients between the GIT and the SF-36 scores were calculated.Results: A group of 97 patients with Ssc with a mean age of 55.37±11.35 years and a female predominance (87.6%) were included in the study. The Cronbach’s alpha value for the UCLA SCTC GIT 2.0 scale was 0.894. ICC was 0.821 (p=0.000). The scale showed acceptable reliability, with the exception of the diarrhea subscale (alpha=0.356). There was a moderate correlation between the total GIT score and the Short Form 36 (SF-36) subscales. All of the items in the scale were included in the validity analysis owing to their reliability.Conclusion: The Turkish GIT 2.0 scale showed good internal consistency, high reliability, and an acceptable validity.

Anahtar Kelime:

Konular: Gastroenteroloji ve Hepatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Meijs J, Pors D, Vliet Vlieland TP, Huizinga TW, Schouffoer AA. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract In - strument (SCTC GIT) 2.0 into Dutch. Clin Exp Rheumatol 2014; 32: 41-8.
Khanna D, Denton CP. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010; 24: 387-400. [CrossRef]
Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009; 360: 1989-2003. [CrossRef]
Bae S, Allanore Y, Coustet B, Maranian P, Khanna D. Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheu -matol 2011; 29: 15-21.
Gyger G, Baron M. Gastrointestinal manifestations of scleroder -ma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 2012; 14: 22-9. [CrossRef]
Sjogren RW, Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996; 8: 569-75. [CrossRef]
Khanna D, Nagaraja V, Gladue H, Chey W, Pimentel M, Frech T. Measuring response in the gastrointestinal tract in systemic sclero -sis. Curr Opin Rheumatol 2013; 25: 700-6. [CrossRef]
Khanna D, Furst DE, Maranian P, et al. Minimally important differ -ences of the UCLA Scleroderma Clinical Trial Consortium Gastroin -testinal Tract Instrument. J Rheumatol 2011; 38: 1920-4. [CrossRef]
Khanna D, Hays RD, Maranian P, et al. Reliability and validity of the Uni - versity of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009; 61: 1257-63. [CrossRef]
Gorga M, Mihai C, Soare AM, Dobrotă R, Gherghe AM, Stoica V. A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheumatol 2015; 33: 61-7.
Gualtierotti R, Ingegnoli F, Two R, VERITAS study group, et al. Re-liability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in pa -tients with systemic sclerosis. Clin Exp Rheumatol 2015; 33: 55-60.
Low AH, Xin X, Law WG, et al. Validation of the UCLA Scleroder -ma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Sin -gapore systemic sclerosis cohort. Clin Rheumatol 2017; 36: 1643-8. [CrossRef]
Zekovic A, Damjanov N. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instru -ment in 104 patients with systemic sclerosis. Rheumatol Int 2017; 37: 735-41. [CrossRef]
Van den Hoogen F, Khanna D, Fransen J, et.al. 2013 classifica - tion criteria for systemic sclerosis: an American college of rheuma - tology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55. [CrossRef]
LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (system - ic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
Bae S, Allanore Y, Furst DE, et al. Associations between a sclero - derma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis. Clin Exp Rheumatol 2013; 31: 57-63.
Baron M, Hudson M, Steele R, Lo E, Canadian Scleroderma Re - search Group. Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis. J Rheumatol 2011; 38: 1925-30. [CrossRef]
Beaton De, Bombardier C, Guillemin F, Bosi Ferrax M: Guidelines for the process of cross- cultural adaptation of self- report mea -sures. Spine 2000; 25: 3186-91. [CrossRef]
Koçyiğit H, Aydemir Ö, Ölmez N, Fişek G. Kısa Form-36’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi 1999; 12: 102-6.

APA	TAŞ Y, DERVİŞ HAKİM G, keskinoglu p, Kenar G, YARKAN H, Zengin B, CAN G, ÖNEN F, Akkoç N, Birlik M, AKARSU M (2019). The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. , 234 - 241.
Chicago	TAŞ Yaşar Murat,DERVİŞ HAKİM Gözde,keskinoglu pembe,Kenar Gokce,YARKAN Handan,Zengin Berrin,CAN GERÇEK,ÖNEN Fatoş,Akkoç Nurullah,Birlik Merih,AKARSU Mesut The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. (2019): 234 - 241.
MLA	TAŞ Yaşar Murat,DERVİŞ HAKİM Gözde,keskinoglu pembe,Kenar Gokce,YARKAN Handan,Zengin Berrin,CAN GERÇEK,ÖNEN Fatoş,Akkoç Nurullah,Birlik Merih,AKARSU Mesut The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. , 2019, ss.234 - 241.
AMA	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. . 2019; 234 - 241.
Vancouver	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. . 2019; 234 - 241.
IEEE	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M "The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society." , ss.234 - 241, 2019.
ISNAD	TAŞ, Yaşar Murat vd. "The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society". (2019), 234-241.

APA	TAŞ Y, DERVİŞ HAKİM G, keskinoglu p, Kenar G, YARKAN H, Zengin B, CAN G, ÖNEN F, Akkoç N, Birlik M, AKARSU M (2019). The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish Journal of Gastroenterology, 30(3), 234 - 241.
Chicago	TAŞ Yaşar Murat,DERVİŞ HAKİM Gözde,keskinoglu pembe,Kenar Gokce,YARKAN Handan,Zengin Berrin,CAN GERÇEK,ÖNEN Fatoş,Akkoç Nurullah,Birlik Merih,AKARSU Mesut The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish Journal of Gastroenterology 30, no.3 (2019): 234 - 241.
MLA	TAŞ Yaşar Murat,DERVİŞ HAKİM Gözde,keskinoglu pembe,Kenar Gokce,YARKAN Handan,Zengin Berrin,CAN GERÇEK,ÖNEN Fatoş,Akkoç Nurullah,Birlik Merih,AKARSU Mesut The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish Journal of Gastroenterology, vol.30, no.3, 2019, ss.234 - 241.
AMA	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish Journal of Gastroenterology. 2019; 30(3): 234 - 241.
Vancouver	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society. Turkish Journal of Gastroenterology. 2019; 30(3): 234 - 241.
IEEE	TAŞ Y,DERVİŞ HAKİM G,keskinoglu p,Kenar G,YARKAN H,Zengin B,CAN G,ÖNEN F,Akkoç N,Birlik M,AKARSU M "The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society." Turkish Journal of Gastroenterology, 30, ss.234 - 241, 2019.
ISNAD	TAŞ, Yaşar Murat vd. "The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society". Turkish Journal of Gastroenterology 30/3 (2019), 234-241.